B2M and chronic kidney disease: Kaplan – Meier analysis of the predicted high/low risk groups illustrated significantly shorter survival time for the high risk group (Fig. 5), suggesting that the combination of HBB, AMBP, B2M and LYZ may efficiently predict survival for patients with CKD.